These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16437968)

  • 1. [Hormone-dependence and C-ERBB2: relationship between estrogen receptor expression, estrogen-regulated proteins, and C-ERBB2 in breast carcinoma].
    Costarelli L; Piro FR; Fortunato L; Vitelli CE; Farina M; Taffuri M; Amini M
    Suppl Tumori; 2005; 4(3):S171. PubMed ID: 16437968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.
    Newby JC; Johnston SR; Smith IE; Dowsett M
    Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of the UROC28 gene in human breast cancer: relationship to ERBB2 gene expression.
    Kamagata C; Tsuji N; Kondoh K; Sasaki M; Kobayashi D; Yagihashi A; Watanabe N
    Anticancer Res; 2002; 22(6C):4087-91. PubMed ID: 12553037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
    Joensuu H; Isola J; Lundin M; Salminen T; Holli K; Kataja V; Pylkkänen L; Turpeenniemi-Hujanen T; von Smitten K; Lundin J
    Clin Cancer Res; 2003 Mar; 9(3):923-30. PubMed ID: 12631589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
    Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M
    Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
    Gong Y; Yan K; Lin F; Anderson K; Sotiriou C; Andre F; Holmes FA; Valero V; Booser D; Pippen JE; Vukelja S; Gomez H; Mejia J; Barajas LJ; Hess KR; Sneige N; Hortobagyi GN; Pusztai L; Symmans WF
    Lancet Oncol; 2007 Mar; 8(3):203-11. PubMed ID: 17329190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p65 and c-erbB2 genes expression in breast tumors: comparison with some histological typing, grading and clinical staging.
    Balcerczak E; Mirowski M; Jesionek-Kupnicka D; Bartkowiak J; Kubiak R; Wierzbicki R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):247-53. PubMed ID: 12866575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
    Arafah M
    Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measures of oestrogen receptor and ERBB2 expression.
    Hayes DF
    Lancet Oncol; 2007 Mar; 8(3):184-5. PubMed ID: 17329185
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
    Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
    Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
    Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
    Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?
    Bird PA; Hill AG; Houssami N
    Ann Surg Oncol; 2008 Jul; 15(7):1983-8. PubMed ID: 18408976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
    Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Her2-Neu expression in ductal adenocarcinomas of the breast gland: correlation with histopathological parameters and estrogen receptors' expression in Mexican patients].
    Brück P; Vilches Cisneros N; Ramos López E; Barboza Quintana O; Ancer Rodríguez J; Flores Gutiérrez JP
    Ginecol Obstet Mex; 2006 Oct; 74(10):516-22. PubMed ID: 21961357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
    Yang JQ; Chen L; Xing TY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):334-6, 357. PubMed ID: 15181828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
    Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors].
    Zhang Z; Xu G; Liu S
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):287-9. PubMed ID: 11038761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
    Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
    Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.